Corbion reported H1 2019 sales of € 471.9 million, an increase of 7.4% compared to H1 2018, mostly because of positive currency effects. Organic sales growth was 0.9%. Adjusted EBITDA in H1 2019 decreased by 0.1% to € 71.4 million due to 0.6% organic growth, positive currency effects, more than offset by a negative impact of the consolidation of the acquired Algae Ingredients plant in Brazil.
“In the first half I was pleased to see a continued acceleration in the organic sales growth rates for our important Food business segment. Ingredient Solutions showed a mixed performance and ended below the targeted sales growth bandwidth as the Biochemicals business segment was facing significant headwinds in Electronics and Agrochemicals. Our EBITDA margins remained at a healthy level in both Food and Biochemicals. In Innovation Platforms we continued on our growth trajectory in the first half. The Total Corbion PLA joint venture saw a very strong performance in H1 2019, supported by positive market developments.
I would like to thank everybody for their support in the past 5 years. It has been my privilege to have served as Corbion's CEO. As I step down, I will be handing over to Olivier Rigaud. I would like to wish Olivier and all Corbion colleagues all the best in taking the business forward”, said Tjerk de Ruiter, CEO.
Key financial highlights first half of 2019
| € million | YTD 2019 | YTD 2018 | Total growth | Organic growth |
| Net sales | 471.9 | 439.2 | 7.4% | 0.9% |
| Adjusted EBITDA | 71.4 | 71.5 | -0.1% | 0.6% |
| Adjusted EBITDA margin | 15.1% | 16.3% | ||
| Operating result | 46.4 | 50.2 | -7.6% | 0.8% |
| ROCE | 10.0% | 14.9% |
Attachment